2021
DOI: 10.1155/2021/8832826
|View full text |Cite
|
Sign up to set email alerts
|

A 6-Year-Old Boy with COVID-19-Positive Pleural Effusion and Kawasaki-Like Features

Abstract: The ongoing outbreak of the novel coronavirus (SARS-CoV-2) has exposed many pediatric patients from around the world to coronavirus disease. Although pleural effusions are classified as atypical features of COVID-19 infection, we report a 6-year-old boy who had a positive IgG antibody ELISA test for COVID-19 and presented with respiratory distress, bilateral pleural effusions, and signs and symptoms of multisystem inflammatory syndrome. The RT-PCR test of the pleural fluid specimen was positive for novel coron… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 5 publications
(6 reference statements)
0
2
0
Order By: Relevance
“…SARS-CoV-2 has also been previously detected by RT-PCR in pleural uid, showing reactive mesothelial cells and lymphocytes in cytology examination, in patients with lung in ltrates 26 , and in children 27 . Viral RNA can also be detected in pleural uid in patients without lung parenchyma involvement 28 .…”
Section: Discussionmentioning
confidence: 83%
“…SARS-CoV-2 has also been previously detected by RT-PCR in pleural uid, showing reactive mesothelial cells and lymphocytes in cytology examination, in patients with lung in ltrates 26 , and in children 27 . Viral RNA can also be detected in pleural uid in patients without lung parenchyma involvement 28 .…”
Section: Discussionmentioning
confidence: 83%
“…The case series by Rostad et al [8] described an incidence of pleural effusions in MIS-C children of 81.8% (the majority of the pleural effusions (67%) were bilateral) compared to 6.3% in COVID-19 infections (P < 0.01). The cytokine storm in COVID-19 patients can occur rapidly, with immune cells attacking the lungs soon after MIS-C [9].…”
Section: Discussionmentioning
confidence: 99%